RecruitingNCT05840575

Investigating Cognitive Impairment in Young Patients With Cancer Prospectively

A Multidisciplinary Neuroscience Approach to Investigate Cognitive Impairment in Young Patients With Cancer Prospectively


Sponsor

Rigshospitalet, Denmark

Enrollment

100 participants

Start Date

Mar 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The MyBrain study investigates the brain function of children, adolescents and young adults during and after chemo treatment for cancer. The tests include 1) cognitive skills such as memory and attention; 2) the brain's electrical activity; 3) and biological markers related to brain function. The aim of the study is to better understand the trajectories of cognitive functioning and measures that have been associated with cognitive impairment in patients treated with chemotherapy.


Eligibility

Min Age: 7 YearsMax Age: 29 Years

Plain Language Summary

Simplified for easier understanding

This study follows young cancer patients ages 7 to 29 through chemotherapy to understand how treatment affects thinking, memory, and concentration — a problem often called chemo brain. Each patient is matched with a healthy person of similar age from their own social circle for comparison. **You may be eligible if...** - You are 7 to 29 years old - You have been newly diagnosed with a non-brain cancer and will be receiving chemotherapy at University Hospital Copenhagen, Rigshospitalet - You speak and understand Danish **You may NOT be eligible if...** - You have a brain tumor or brain metastases - You have a severe intellectual disability or mental health condition that makes participation too difficult - You are in a terminal stage of illness - You do not speak Danish Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Rigshospitalet

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05840575


Related Trials